Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Allison Trail"'
Autor:
Brian D. Badgwell, Catherine E Devine, Yang Lu, Jane E. Rogers, Ahmed Abdelhakeem, Allison Trail, Naruhiko Ikoma, Tara Sagebiel, Xuemei Wang, Jeannelyn S. Estrella, Madhavi Patnana, Jaffer A. Ajani, Mariela A. Blum Murphy
Publikováno v:
Oncology. 99:659-664
Background: The value of baseline fluorodeoxyglucose-positron emission tomography-computed tomography (PET-CT) remains uncertain once gastroesophageal cancer is metastatic. We hypothesized that assessment of detailed PET-CT parameters (maximum standa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2c6af64351895fe9c007adb5e658d2
https://doi.org/10.1159/000517842
https://doi.org/10.1159/000517842
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 20(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ec3e7a9bd029168f6bf7bd66d2d867
https://pubmed.ncbi.nlm.nih.gov/35130503
https://pubmed.ncbi.nlm.nih.gov/35130503
Publikováno v:
Oncology. 100(3)
Background: Platinum + fluoropyrimidine is a standard front-line therapy for unresectable gastroesophageal adenocarcinoma (GA). Subsequent therapy recommendations are ramucirumab + paclitaxel (RAM/PAC), taxane, irinotecan, or trifluridine-tipiracil.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3572757ad18623aa0485c0b1b0f30a0e
https://pubmed.ncbi.nlm.nih.gov/34969028
https://pubmed.ncbi.nlm.nih.gov/34969028
Autor:
Allison Trail
Publikováno v:
Journal of the Advanced Practitioner in Oncology
This article will review the case of a 53-year-old female with a diagnosis of metastatic esophageal cancer receiving treatment on a clinical trial protocol combining chemotherapy/immunotherapy with FOLFOX and nivolumab, who presents to the clinic wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e14dba1494d9b88b307fb14f0805403
https://pubmed.ncbi.nlm.nih.gov/33489428
https://pubmed.ncbi.nlm.nih.gov/33489428
Autor:
Jaffer A. Ajani, Xuemei Wang, Allison Trail, Meina Zhao, Jeannelyn S. Estrella, Jane E. Rogers, Ahmed K. Abdelhakeem, Mariela Blum-Murphy
Publikováno v:
Oncology. 98(12)
Background: Prior studies have shown that patients whose tumor overexpresses Her2 at 3+ level by immunohistochemistry (IHC) fare better than those whose tumor overexpresses Her2 at 2+ level (with ERBB2 amplified). Therefore, it would be important to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b1f82372bec9e2dfcec2f2d5f40782e
https://pubmed.ncbi.nlm.nih.gov/32998149
https://pubmed.ncbi.nlm.nih.gov/32998149
Autor:
Masaaki Iwatsuki, Brian D. Badgwell, Ahmed Abdelhakeem, Jeffrey H. Lee, Jaffer A. Ajani, Jane E. Rogers, Brian Weston, Kazuto Harada, Quynh Nhu Nguyen, Stephen G. Swisher, Allison Trail, Mariela A. Blum Murphy, Namita Shanbhag, Naruhiko Ikoma, Manoop S. Bhutani, Prajnan Das, Meina Zhao, Wayne L. Hofstetter, Xuemei Wang, Dipen M. Maru, Hyunsoo Hwang
Publikováno v:
Gastric Cancer
BACKGROUND: As cancer patients are surviving longer, more patients manifest brain metastases (BRM). However, the rate of BRM from upper gastrointestinal cancer is unclear. We therefore evaluated the frequency and prognostic effect of BRM in this sett
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81e399bd8e02211a7a6e5283200525df
https://europepmc.org/articles/PMC7442686/
https://europepmc.org/articles/PMC7442686/
Autor:
Jane E. Rogers, Lianchun Xiao, Melissa Palmer, Mariela A. Blum Murphy, Allison Trail, Jaffer A. Ajani
Publikováno v:
Oncology. 98(5)
Introduction: Advanced unresectable gastroesophageal cancers continue to confer a dismal patient prognosis. Limited options remain once the cancer is refractory to cytotoxics/biologics (like irinotecan, taxane, and ramucirumab). Recently, anti-progra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8340ae5aa08ed5aac68a9972e5db04e
https://pubmed.ncbi.nlm.nih.gov/32097933
https://pubmed.ncbi.nlm.nih.gov/32097933
Autor:
Catherine E Devine, Brian D. Badgwell, Yang Lu, Allison Trail, Jane E. Rogers, Prajnan Das, Rebecca E Waters, Madhavi Patnana, Ahmed Abdelhakeem, Xuemei Wang, Jaffer A. Ajani, Naruhiko Ikoma, Jeannelyn S. Estrella, Mariela A. Blum Murphy
Publikováno v:
Cancers, Vol 13, Iss 420, p 420 (2021)
Cancers
Volume 13
Issue 3
Cancers
Volume 13
Issue 3
Diffuse type of gastric adenocarcinoma (dGAC) generally confers a poor prognosis compared to intestinal type. Some dGACs are not avid on fluorine-18 fluoro-2-deoxy-D-glucose PET (FDG-PET) while others seem to consume glucose avidly. We analyzed the o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7ca5fe121abd05d4bc6ddb47dda037e
https://doi.org/10.3390/cancers13030420
https://doi.org/10.3390/cancers13030420
Autor:
Rebecca E Waters, Naruhiko Ikoma, Catherine E Devine, Jaffer A. Ajani, Allison Trail, Yang Lu, Jane E. Rogers, Mariela Blum-Murphy, Ahmed Abdelhakeem, Xuemei Wang, Madhavi Patnana, Brian D. Badgwell, Jeannelyn S. Estrella
Publikováno v:
Journal of Clinical Oncology. 39:176-176
176 Background: Diffuse type of gastric adenocarcinoma (dGAC) confers a poor but variable prognosis compared to intestinal type of GAC. The value of baseline uptake of FDG-PET in localized dGAC is unclear and ~40% are not FDG-PET avid. We analyzed ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c4357783a61cb5e7d192477456c362d
https://doi.org/10.1200/jco.2021.39.3_suppl.176
https://doi.org/10.1200/jco.2021.39.3_suppl.176
Autor:
Irene Thomas, Jaffer A. Ajani, Xuemei Wang, Allison Trail, Mariela Blum-Murphy, Jane E. Rogers, Ahmed Abdelhakeem, Meina Zhao
Publikováno v:
Journal of Clinical Oncology. 38:291-291
291 Background: In untreated patients with HER2 positive advanced gastroesophageal adenocarcinoma (AGEA), trastuzumab plus active cytotoxic combination is the standard of care. Our objective was to assess the role of maintenance therapy (trastuzumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb3696320070d263204a5fb37b8466ed
https://doi.org/10.1200/jco.2020.38.4_suppl.291
https://doi.org/10.1200/jco.2020.38.4_suppl.291